Cannabis Suisse CORP
Market Movers (8-K)
OID
Cannabis Suisse Corp. issued a significant number of shares to its CEO through a convertible note conversion, and also issued shares to legal and accounting service providers.
Worse than expected
OID
Cannabis Suisse Corp. has dismissed Accell Audit & Compliance and appointed MAC Accounting Group as its new independent auditor, effective March 14, 2024.
Quarterly Earnings (10-Q)
OID
Cannabis Suisse Corp. reported net income for the third quarter ended February 28, 2026, a shift from the previous year's loss, driven by changes in debt settlement and premium amortization.
Capital raise
OID
Cannabis Suisse Corp. reported a net income of $36,299 for the six months ended November 30, 2025, despite generating no revenue, while facing significant going concern doubts and material weaknesses in internal controls.
Capital raise
Worse than expected
OID
Cannabis Suisse Corp. reported zero revenue for the quarter ended August 31, 2025, with cash balances at a critically low $305 and significant internal control weaknesses.
Worse than expected
Capital raise
OID
Cannabis Suisse Corp.'s Q3 2025 filing reveals a net loss and ongoing concerns about the company's ability to continue as a going concern.
Capital raise
Worse than expected
OID
Cannabis Suisse Corp.'s Q2 2025 report reveals a net income of $5,062 for the three months ended November 30, 2024, but significant accumulated losses and a going concern warning remain.
Worse than expected
Capital raise
OID
Cannabis Suisse Corp.'s Q1 2025 results show a significant increase in net loss compared to the same period last year, alongside a going concern warning.
Worse than expected
Capital raise
Annual Reports (10-K)
OID
Cannabis Suisse Corp. filed an amendment to its annual report to include the previously omitted date of its independent auditor's report, which noted a going concern issue.
Worse than expected
OID
Cannabis Suisse Corp. faces significant financial challenges with a substantial net loss and a going concern opinion, despite exiting the cannabis industry.
Worse than expected
Delay expected
Capital raise
OID
Cannabis Suisse Corp. has filed an amended annual report to correct a lease accounting error, restating its financial statements for the fiscal year ended May 31, 2024.
Worse than expected
Capital raise
OID
Cannabis Suisse Corp.'s 10-K filing reveals a net loss of $1.26 million for fiscal year 2024 and a going concern warning due to limited operations and reliance on CEO funding.
Worse than expected
Capital raise